[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365866-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365866-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","artificial-intelligence-in-cancer-epigenomics-a-review-on-advances-in-pan-cancer-detection-and-precision-medicine","Artificial Intelligence in cancer epigenomics - a review on advances in pan-cancer detection and precision medicine","","DNA methylation is a fundamental epigenetic modification that regulates gene expression and maintains genomic stability. As a key biomarker in cancer research, it supports diagnosis, prognosis, and tailored treatment selection. Aberrant methylation patterns enable early detection and therapeutic stratification, but their complexity requires advanced analytics. Recent AI and machine learning, including deep learning and graph-based models, enable rapid, high-resolution analysis of DNA methylation profiles and accelerate Multi-Cancer Early Detection tests. Remaining challenges include limited early-stage sensitivity, black-box models, and the need for validation across diverse populations to enable equitable use.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/artificial-intelligence-in-cancer-epigenomics-a-review-on-advances-in-pan-cancer-detection-and-precision-medicine/365866/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/artificial-intelligence-in-cancer-epigenomics-a-review-on-advances-in-pan-cancer-detection-and-precision-medicine/365866.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is DNA methylation important in cancer research?","Question",{"text":63,"@type":64},"DNA methylation regulates gene expression and maintains genomic stability. Its abnormal patterns act as biomarkers supporting diagnosis, prognosis, and treatment stratification across cancer stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does AI improve analysis of DNA methylation profiles?",{"text":68,"@type":64},"AI and machine learning methods, including deep learning networks and graph-based models, enable rapid, high-resolution analysis of methylation data. This supports early detection and more accurate classification for precision oncology.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges remain for AI-driven epigenetic diagnostics?",{"text":72,"@type":64},"Key challenges include limited sensitivity for early-stage cancers, the black-box nature of many algorithms, and the need for validation across diverse populations to ensure equitable implementation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365866,1790388735,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":113,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Sahoo et al. Epigenetics & Chromatin (2025) 18:35 [https://doi.org/10.1186/s13072-025-00595-5](https://doi.org/10.1186/s13072-025-00595-5)  \nEpigenetics & Chromatin  \n REVIEW Open Access  \nArtificial Intelligence in cancer epigenomics:   a review on advances in pan-cancer detection and precision medicine  \nKarishma Sahoo1, Prakash Lingasamy2,3, Masuma Khatun4, Sajitha Lulu Sudhakaran 1, Andres Salumets2,3,5*, Vino Sundararajan1 and Vijayachitra Modhukur2,3*  \nAbstract  \nDNA methylation is a fundamental epigenetic modification that regulates gene expression and maintains genomic stability. Consequently, DNA methylation remains a key biomarker in cancer research, playing a vital role in diagnosis, prognosis, and tailored treatment strategies. Aberrant methylation patterns enable early cancer detection and therapeutic stratification; however, their complex patterns necessitates advanced analytical tools. Recent advances in artificial intelligence (AI) and machine learning (ML), including deep learning networks and graph-based models, have revolutionized cancer epigenomics by enabling rapid, high-resolution analysis of DNA methylation profiles. Moreover, these technologies are accelerating the development of Multi-Cancer Early Detection (MCED) tests, such as GRAIL’s Galleri and CancerSEEK, which improve diagnostic accuracy across diverse cancer types. In this review, we explore the synergy between AI and DNA methylation profiling to advance precision oncology. We first examine the role of DNA methylation as a biomarker in cancer, followed by an overview of DNA profiling technologies. We then assess how AI-driven approaches transform clinical practice by enabling early detection and accurate classification. Despite their promise, challenges remain, including limited sensitivity for early-stage cancers, the black-box nature of many AI algorithms, and the need for validation across diverse populations to ensure equitable implementation. Future directions include integrating multi-omics data, developing explainable AI frameworks, and addressing ethical concerns, such as data privacy and algorithmic bias. By overcoming these gaps, AI-powered epigenetic diagnostics can enable earlier detection, more effective treatments, and improved patient outcomes, globally. In summary, this review synthesizes current advancements in the field and envisions a future where AI and epigenomics converge to redefine cancer diagnostics and therapy.  \nKeywords DNA methylation, Artificial intelligence, Machine learning, Deep learning, Cancer epigenomics, Pancancer, Early detection, Precision oncology, Liquid biopsy, Multi-omics, Multi-cancer diagnostics  \n*Correspondence:  \nAndres Salumets [andres.salumets@ki.se](andres.salumets@ki.se)[ ](andres.salumets@ki.se)Vijayachitra Modhukur [vijayachitra.modhukur@ut.ee](vijayachitra.modhukur@ut.ee)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025, corrected publication 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nSahoo et al. Epigenetics & Chromatin (2025) 18:35  \nIntroduction  ","cbCaitMQfEd8vEX7","https://ap.wps.com/l/cbCaitMQfEd8vEX7","pdf",4189589,"English","# Abstract\n# Introduction\n# Epigenetics & Chromatin","[{\"question\":\"Why is DNA methylation important in cancer research?\",\"answer\":\"DNA methylation regulates gene expression and maintains genomic stability. Its abnormal patterns act as biomarkers supporting diagnosis, prognosis, and treatment stratification across cancer stages.\"},{\"question\":\"How does AI improve analysis of DNA methylation profiles?\",\"answer\":\"AI and machine learning methods, including deep learning networks and graph-based models, enable rapid, high-resolution analysis of methylation data. This supports early detection and more accurate classification for precision oncology.\"},{\"question\":\"What challenges remain for AI-driven epigenetic diagnostics?\",\"answer\":\"Key challenges include limited sensitivity for early-stage cancers, the black-box nature of many algorithms, and the need for validation across diverse populations to ensure equitable implementation.\"}]","Artificial Intelligence in cancer epigenomics - a review on advances in pan-cancer detection and precision medicine | PDF",1790162730,76,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee19ba90d9de84189681ab17b4bff03f.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45addb6a4e259b5f1c785515c8e0c537.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3971fd86a107a8ad212f0858a5900a3.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0929444761c6b522fda63927155a17ad.webp",980,1301]